Wave Life Sciences (WVE) Change in Cash (2014 - 2026)
Wave Life Sciences posted quarterly Change in Cash of -$57.5 million for Q1 2026, up 2.58% year-on-year from -$56.0 million in Q1 2025, and down 114.16% on a QoQ basis from $405.9 million in Q4 2025.
Wave Life Sciences (WVE) has 13 years of Change in Cash data on file, last reported at -$57.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 2.58% year-over-year to -$57.5 million; the trailing twelve-month figure through Mar 2026 stood at $301.6 million (up 384.74% YoY), and the FY2025 full-year result was $300.0 million, up 194.77% from the prior year.
- Change in Cash for Q1 2026 stood at -$57.5 million, down from $405.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $405.9 million in Q4 2025 and bottomed at -$88.9 million in Q1 2022.
- The 5-year median for Change in Cash is -$19.4 million (2024), against an average of $23.2 million.
- Peak annual rise in Change in Cash reached 4682.88% in 2025, while the deepest fall reached 203.87% in 2025.
- A 5-year view of Change in Cash shows it stood at -$8.5 million in 2022, then jumped by 815.0% to $60.4 million in 2023, then plunged by 114.66% to -$8.9 million in 2024, then jumped by 4682.88% to $405.9 million in 2025, then tumbled by 114.16% to -$57.5 million in 2026.
- The last three Change in Cash figures came in at -$57.5 million (Q1 2026), $405.9 million (Q4 2025), and -$12.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | -57.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.47 Mn |
| Dec 31, 2025 | 405.86 Mn |
| Sep 30, 2025 | -12.25 Mn |
| Jun 30, 2025 | -34.58 Mn |
| Mar 31, 2025 | -58.99 Mn |
| Dec 31, 2024 | -8.86 Mn |
| Sep 30, 2024 | 157.01 Mn |
| Jun 30, 2024 | -26.95 Mn |
| Mar 31, 2024 | -19.41 Mn |
| Dec 31, 2023 | 60.43 Mn |
| Sep 30, 2023 | -33.02 Mn |
| Jun 30, 2023 | -35.58 Mn |
| Mar 31, 2023 | 120.07 Mn |
| Dec 31, 2022 | -8.45 Mn |
| Sep 30, 2022 | -26.21 Mn |
| Jun 30, 2022 | 61.45 Mn |
| Mar 31, 2022 | -88.85 Mn |
| Dec 31, 2021 | 26.67 Mn |
| Sep 30, 2021 | -19.94 Mn |
| Jun 30, 2021 | -4.70 Mn |
| Mar 31, 2021 | -35.96 Mn |
| Dec 31, 2020 | -31.87 Mn |
| Sep 30, 2020 | 122.31 Mn |
| Jun 30, 2020 | -26.89 Mn |
| Mar 31, 2020 | -26.21 Mn |
| Dec 31, 2019 | -61.84 Mn |
| Sep 30, 2019 | -43.89 Mn |
| Jun 30, 2019 | -34.66 Mn |
| Mar 31, 2019 | 112.75 Mn |
| Dec 31, 2018 | -35.67 Mn |
| Sep 30, 2018 | -30.94 Mn |
| Jun 30, 2018 | 130.94 Mn |
| Mar 31, 2018 | -32.01 Mn |
| Dec 31, 2017 | -25.96 Mn |
| Sep 30, 2017 | -28.93 Mn |
| Jun 30, 2017 | 67.91 Mn |
| Mar 31, 2017 | -20.81 Mn |
| Dec 31, 2016 | -16.18 Mn |
| Sep 30, 2016 | -12.75 Mn |
| Jun 30, 2016 | 28.37 Mn |
| Mar 31, 2016 | -7.82 Mn |
| Dec 31, 2015 | 95.18 Mn |
| Sep 30, 2015 | 58.26 Mn |
| Jun 30, 2015 | -3.18 Mn |
| Mar 31, 2015 | 9.91 Mn |
| Dec 31, 2014 | -1.44 Mn |